Joseph C. Papa, CHAIRMAN & CEO at Valeant Pharmaceuticals International, Inc. (VRX), bought 30,000 shares at $16.05 ($482K) on 2018-03-13, disclosed to the SEC on 2018-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RXDX | BUY | 2021-03-16 | $285K | — | Filing → |
| BHC | BUY | 2019-09-13 | $699K | — | Filing → |
| BHC | BUY | 2019-02-28 | $710K | — | Filing → |